Neuronal death mechanisms in cerebral ischemia;Mecanismos de muerte neuronal en la isquemia cerebral

Revista de Neurologia

Volumn 29, Issue 6, 1999, Pages 515-521

  Ferrer, I ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Bax; Bcl 2; Bcl x; Brain derived neurotrophic factor; C jun N terminal kinase 1; C jun; Caspase; Necrosis; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ONCOPROTEIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR;

BRAIN ISCHEMIA; CELL DEATH; CELL PROTECTION; CONFERENCE PAPER; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0033619053     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2906.99173     Document Type: Conference Paper

References (118)

1. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In Tomei LD, Cope FO, eds. Apoptosis: the molecular basis of cell death. New York: Cold Spring Harbor Laboratory Press; 1991. p. 5-30.
2. Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J 1992; 6: 2450-5.
3. Buja LM, Eigenbrodt ML, Eigenbrodt EH. Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 1993; 117: 1208-14.
4. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
5. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991; 7: 663-98.
6. Driscoll M. Cell death in C. elegans: molecular insights into mechanisms conserved between nematodes and mammals. Brain Pathol 1996; 6: 411-25.
7. Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 1994; 86: 1286-96.
8. Wyllie AH. The genetic regulation of apoptosis. Curr Opin Genet Dev 1995; 5: 97-104.
9. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-9.
10. Kroemer G, Petit P, Zamzami N, Vayssière JL, Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 9: 1277-87.
11. Raff MC. Social controls on cell survival and cell death. Nature 1992; 356: 397-400.
12. Silos-Santiago I, Greelund LJS, Johnson EM, Snider WD. Molecular genetics of neuronal survival. Curr Opin Neurobiol 1995; 5: 42-9.
13. Burek MJ, Oppenheim RW. Programmed cell death in the developing nervous system. Brain Pathol 1996; 6: 427-46.
14. Tominaga T, Kure S, Narisawa K, Yoshimoto T. Endonuclease activation following focal ischemic injury in the rat brain. Brain Res 1993; 608: 21-6.
15. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993; 24: 2002-9.
16. MacManus JP, Hill IE, Huang ZG, Rasquinha I, Xue D, Buchan AM. DNA damage consistent with apoptosis in transient focal ischemic neocortex. Neuroreport 1994; 5: 493-6.
17. Li Y, Chopp M, Jiang N, Yao F, Zaloga C. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1995; 15: 389-97.
18. Linnik MD, Miller JA, Sprinkle-Cavallo J, Mason PJ, Thompson FY, Montgomery LR, et al. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion. Mol Brain Res 1995; 32: 116-24.
19. MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett 1993; 164: 89-92.
20. Héron A, Pollard H, Dessi F, Moreau J, Lasbennes F, Ben-Ari Y, et al. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain. J Neurochem 1993; 61: 1973-6.
21. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995; 15: 1001-11.
22. Ferrer I, Tortosa A, Macaya A, Sierra A, Moreno D, Munell F, et al. Evidence of internucleosomal DNA fragmentation following hypoxiaischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil. Brain Pathol 1994; 4: 115-22.
23. Hill IE, MacManus JP, Rasquinha I, Tuor UI. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res 1995; 676: 398-403.
24. Beilharz EJ, Williams CE, Dragunow M, Sirimanne ES, Gluckman PD. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Mol Brain Res 1995; 29: 1-14.
25. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 1995; 7: 61-4.
26. De Torres C, Munell F, Ferrer I, Reventós J, Macaya A. Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain. Neurosci Lett 1997; 230: 1-4.
27. Sheng M, Greenberg ME. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 1990; 4: 477-85.
28. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 1991; 14: 421-51.
29. Herdegen T, Zimmermann M. Expression of c-Jun and Jun D transcription factors represent specific changes in neuronal gene expression following axotomy. Progr Brain Res 1994; 103: 153-71.
30. Gass P, Herdegen T. Neuronal expression of AP-1 proteins in excitotoxic-neurodegenerative disorders and following nerve fiber lesions. Progr Neurobiol 1995; 47: 257-90.
31. Dragunow M, Preston K. The role of inducible transcription factors in apoptotic cell death. Brain Res Rev 1995; 21: 1-28.
32. Ferrer I, Olivé M, Ribera J, Planas AM. Naturally-occurring (programmed) and radiation-induced apoptosis are associated with selective c-Jun expression in the developing rat brain. Eur J Neurosci 1996; 8: 1286-98.
33. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev 1993; 7: 2135-48.
34. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, et al. JNK-1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-37.
35. Herdegen T, Skene P, Bähr M. The c-Jun protein-transcriptional mediator of neuronal survival, regeneration and death. Trends Neurosci 1997; 20: 227-31.
36. An G, Lin TN, Liu JS, Xue JJ, He YY, Hsu CY. Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann Neurol 1993; 33: 457-64.
37. Comelli MC, Guidolin D, Seren MS, Zanoni R, Canella R, Rubini R, et al. Time course, localization and pharmacological modulation of immediate early inducible genes, brain-derived neurotrophic factor and trkB messenger mRNAs in the rat brain following photochemical stroke. Neuroscience 1993; 55: 473-90.
38. Gass P, Spranger M, Herdegen T, Bravo R, Köck P, Hacke W, el al. Induction of FOS and JUN proteins after focal ischemia in the rat: differential effect of the N-methyl-D-aspartate receptor antagonist MK-801. Acta Neuropathol 1992; 84: 545-53.
39. Kiessling M, Gass P. Stimulus-transcription coupling in focal cerebral ischemia. Brain Pathol 1994; 4: 77-83.
40. Planas AM, Ferrer I. Expressió gènica en models d'isquèmia cerebral. Treballs Soc Cat Biol 1996; 47: 227-17.
41. Guégan C, Lévy V, David J P, Ajchenbaum-Cymbalista F, Sola B. c-Jun and cyclin D1 proteins as mediators of neuronal death after focal ischemic insult. Neuroreport 1997; 8: 1003-7.
42. Hermann DM, Kuroiwa T, Ito U, Mies G. Expression of c-jun, hsp-72 and GFAP following repeated unilateral common carotid artery occlusion in gerbils-correlates of delayed ischemic injury. Brain Res 1998; 799: 35-43.
43. Herdegen T, Claret FX, Kallunki T, Martín-Villalba A, Winter C, Hunter T, et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci 1998; 18: 5124-35.
44. Nowak TS, Osborne OC, Suga S. Stress protein and proto-oncogene expression as indicators of neuronal pathophysiology after ischemia. Progr Brain Res 1993; 96: 195-208.
45. Kiessling M, Stumm G, Xie Y, Herdegen T, Aguzzi A, Bravo R, et al. Differential transcription and translation of immediate early genes in the gerbil hippocampus after transient global ischemia. J Cereb Blood Flow Metab 1993; 13: 914-24.
46. Takemoto O, Tominoto H, Yanagihara T. Induction of c-fos and c-jun gene products and heat shock protein after brief and prolonged cerebral ischemia in gerbils. Stroke 1995; 26: 1639-48.
47. Sommer C, Gass P, Kiessling M. Selective c-Jun expression in CA1 neurons of the gerbil hippocampus during and after acquisition of an ischemic tolerant state. Brain Pathol 1995; 5: 135-44.
48. Ferrer I, Ballabriga J, Pozas E. Transient forebrain ischemia in the adult gerbil is associated with a complex c-Jun response. Neuroreport 1997; 8: 2483-7.
49. Gubits RM, Burke RE, Casey-Macintosh G, Bendele A, Munell F. Immediate early gene induction after neonatal hypoxia-ischemia. Mol Brain Res 1993; 18: 228-38.
50. Munell F, Burke RE, Bandele A, Gubits RM. Colocalization of c-fos, c-jun and hsp-70 mRNA expression in brain after neonatal hypoxia-ischemia. Dev Brain Res 1994; 77: 111-21.
51. Macaya A, Munell F, Ferrer I, de Torres C, Reventós J. Cell death and associated c-jun induction in perinatal hypoxia-ischemia. Effects of the neuroprotective drug dexamethasone. Mol Brain Res 1998; 56: 29-37.
52. Ferrer I. Cell death in the normal developing brain, and following ionizing radiation, methyl-azoxymethanol acetate, and hypoxia-ischaemia in the rat. Neuropathol Appl Neurobiol 1996; 22: 489-94.
53. Dragunow M, Beilharz E, Sirimanne E, Lawlor P, Williams C, Bravo R, et al. Immediate-early gene protein expression in neurons undergoing delayed cell death, but not necrosis, following hypoxic-ischemic injury to the young rat brain. Mol Brain Res 1994; 25: 19-33.
54. Gilby KL, Armstrong JN, Currie RW, Robertson HA. The effects of hypoxia-ischemia on expression of c-Fos, c-Jun and HSP-70 in the young rat hippocampus. Mol Brain Res 1997; 48: 87-96.
55. Davies JC. The Bcl-2 family of proteins, and the regulation of cell survival. Trends Neurosci 1995;18: 355-8.
56. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997; 20: 245-67.
57. Hockenberry D, Núñez G, Milliman CL, Scheriber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
58. Korsmeyer SJ. Bcl-2: a repressor of lymphocyte death. Immunol Today 1992;13: 285-8.
59. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
60. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptosic cell death. Cell 1993; 74: 597-608.
61. González-García M, Pérez-Ballesteros R, Ding L, Duan L, Boise LH, Thompson CB, et al. Bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes in mitochondria. Development 1994;120: 3033-42.
62. Minn AJ, Boise LH, Thompson CB. Bcl-x(S) antagonizes the protective effects of Bcl-x(L). J Biol Chem 1996; 271: 6306-12.
63. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994; 74: 609-19.
64. Martinou JC, Dubois-Dauphin M, Staple JK, Rodríguez I, Frakowski H, Missotten M, et al. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13: 1017-30.
65. Linnik MD, Zahos P, Geschwind MD, Fedoroff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 1995; 26: 1670-4.
66. Lawrence MS, Ho DY, Sun GH, Steinberg GK, Sapolsky RM. Over-expression of bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 1996; 16: 486-96.
67. Guillardon F, Lenz C, Waschke KF, Krajewski S, Reed JC, Zimmermann M, et al. Altered expression of Bcl-2, Bcl-x, Bax, and c-Fos co-localizes with DNA fragmentation and ischemic damage following middle cerebral artery occlusion in rats. Mol Brain Res 1996; 40: 254-60.
68. Matsushita K, Matsuyama T, Kitagawa K, Matsumoto M, Yanagihara T, Sugita M. Alterations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct cortex following focal cerebral ischemia in mice. Neuroscience 1998; 83: 439-48.
69. Chen J, Graham SH, Chan PH, Lan J, Zhou RL, Simon RP. Bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport 1995; 6: 394-8.
70. Isenmann S, Stoll G, Schroeter M, Krajewski S, Reed JC, Bahra M. Differential regulation of Bax, Bcl-2, and Bcl-x proteins in focal cortical ischemia in the rat. Brain Pathol 1998; 8: 49-62.
71. Honkaniemi J, Massa S, Breckinridge M, Sharp FR. Global ischemia induces apoptosis-associated genes in hippocampus. Mol Brain Res 1996; 42: 79-88.
72. Shimazaki K, Ishida A, Kawai N. Increase in Bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci Res 1994; 20: 95-9.
73. Hara A, Iwai T, Niwa M, Uematsu T, Yoshimi N, Tanaka T, et al. Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res 1996; 711: 249-53.
74. Niwa M, Hara A, Iwai T, Sassa T, Mori H, Uematsu T. Expression of Bax and Bcl-2 protein in the gerbil hippocampus following transient forebrain ischemia and its modifications by phecycline. Neurol Res 1997; 19: 629-33.
75. Chen J, Zhu RL, Nakayama M, Kawaguchi K, Jin K, Stetler RA, et al. Expression of the apoptosis effector gene bax is up-regulated in vulnerable hippocampal neurons following global ischemia. J Neurochem 1996; 67: 64-71.
76. Krajewski S, Mai JK, Krajewska M, Sikorska A, Mossakowski MJ, Reed JC. Upregulation of Bax protein levels in neurons following cerebral ischemia. J Neurosci 1995; 15: 6364-76.
77. Ferrer I, López E, Blanco R, Rivera R, Ballabriga J, Pozas E, et al. Bcl-2, Bax, and Bcl-x expression in the CA1 area of the hippocampus following transient forebrain ischemia in the adult gerbil. Exp Brain Res 1998; 121: 167-73.
78. Dixon ED, Stephenson DT, Clemens JA, Little SP. Bcl-x-S is elevated following severe global ischemia in rat brain. Brain Res 1997; 776: 222-9.
79. MacGibbon GA, Lawlor PA, Sirimanne ES, Walton MR, Connor B, Young D, et al. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res 1997; 750: 223-34.
80. Ferrer I, Pozas E, López E, Ballabriga J. Bcl-2, Bax and Bcl-x expression following hypoxia-ischemia in the infant rat brain. Acta Neuropathol 1997; 94: 583-9.
81. Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 1998; 18: 1009-19.
82. Kumar S, Lavin MF. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ 1996; 3: 255-67.
83. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16.
84. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem 1997; 22: 299-306.
85. Van de Craen M, Vandenabeele P, Declerq W, van den Brande I, van Loo G, Kolemans F, et al. Characterization of seven murine caspase family members. FEBS Lett 1997; 403: 61-9.
86. Friedlander RM, Yuan J. ICE, neuronal apoptosis and neurodegeneration. Cell Death Differ 1998; 5: 823-31.
87. Stroh C, Schulze-Osthoff K. Death by thousand cuts: an even increasing list of caspase substrates. Cell Death Differ 1998; 5: 997-1000.
88. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254: 439-59.
89. Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, et al. Expression of a dominant negative mutant of ICE in transgenic mice prevents neuronal cell death induced by trophic factors withdrawal and ischemic brain injury. J Exp Med 1997; 185: 933-40.
90. Hara H, Fink K, Endres M, Friedlander RM, Gagliardini V, Yuan J, et al. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitor protein. J Cereb Blood Flow Metab 1997; 17: 370-5.
91. Schielke GP, Yang GY, Shivers BD, Betz AL. Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998; 18: 180-5.
92. Loddick SA, MacKenzie A, Rothwell NJ. An ICE inhibitor, z-VAD-DCB attenuates ischemic brain damage in the rat. Neuroreport 1996; 7: 1465-8.
93. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, et al. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94: 2007-12.
94. Bhat RV, DiRocco R, Marcy VR, Flood DG, Zhu Y, Dobrzanski P, et al. Increased expression of IL-1β converting enzyme in hippocampus after ischemia: selectivç localization in microglia. J Neurosci 1996; 16: 4146-54.
95. Nath R, Probert A, McGinnis KK, Wang KK. Evidence of activation of caspase-3-like protease in excitotoxin- and hypoxic/hypoglycemic-injured neurons. J Neurochem 1998; 71: 186-95.
96. Asaki M, Hoshimaru M, Uemura Y, Tokime T, Kojima M, Ohtsuka T, et al. Expression of interleukin-1β converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery. J Cereb Blood Flow Metab 1997; 17: 11-8.
97. Nawamura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998; 18: 3659-68.
98. Chen J, Nagayama T, Jin K. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18: 4914-28.
99. Barde YA. Neurotrophins: a family of proteins supporting the survival of neurons. Progr Clin Biol Res 1994; 390: 45-56.
100. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell Biol 1995; 7: 148-55.
101. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995; 18: 223-53.
102. Lewin GR, Barde YA. Physiology of neurotrophins. Annu Rev Neurosci 1996; 19: 289-317.
103. Arai S, Kinouchi H, Akabane A, Owada Y, Kamii H, Kawase M, et al. Induction of brain-derived neurotrophic factor (BDNF) and the receptor TrkB mRNA following middle cerebral artery occlusion in rat. Neurosci Lett 1996; 211: 57-60.
104. Lin TN, Chen JJ, Wang SJ, Cheng JT, Chi SI, Shyu AB, et al. Expression of NGFI-B mRNA in a rat focal ischemia-reperfusion model. Mol Brain Res 1996; 43: 149-56.
105. Kokaia Z, Zhao Q, Kokaia M, Elmer E, Metsis M, Smith ML, et al. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral occlusion with and without brain damage. Exp Neurol 1995; 136: 73-88.
106. Lindwall O, Ernfors P, Bengzon J, Kokaia Z, Smith ML, Siesjo BK, et al. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 1992; 89: 698-52.
107. Kokaia Z, Nawa H, Uchino H, Elmer E, Kokaia M, et al. Regional brain-derived neurotrophic factor mRNA and protein levels following transient forebrain ischemia in the rat. Mol Brain Res 1996; 38: 139-44.
108. Schäbitz WK, Schwab S, Spranger M, Hacke W. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1997; 17: 500-6.
109. Yamashita K, Wiessner C, Lindholm D, Thoenen H, Hossmann KA. Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat. Metab Brain Dis 1997; 12: 271-80.
110. Tsukahara T, Yonekawa Y, Tanaka K, Ohara O, Watanabe S, Kimura T, et al. The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery 1996; 34: 323-31.
111. Beck T, Lindholm D, Castrén E, Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab 1994; 14: 689-92.
112. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani M, et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995; 374: 450-3.
113. Ferrer I, Ballabriga J, Martí E, Pozas E, Planas AM, Blasi J. BDNF and TrkB co-localize in CA1 neurons resistant to transient forebrain ischemia in the adult gerbil. J Neuropathol Exp Neurol 1997; 56: 790-7.
114. Ferrer I, Ballabriga J, Martí E, Pérez E, Alberch J, Arenas E. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol 1998; 8: 253-61.
115. Dragunow M, Beilharz E, Sirimanne E, Lawlor P, Williams C, Branco R, et al. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain. Mol Brain Res 1994; 25: 19-33.
116. Narumiya S, Ohno M, Tanaka N, Yamano T, Shimada M. Enhanced expression of full-length TrkB receptors in young rat brain with hypoxic-ischemic injury. Brain Res 1998; 797: 278-86.
117. Cheng Y, Gidday JM, Yan Q, Shah AR, Holtzman DM. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol 1997; 41: 521-9.
118. Tamatani M, Ogawa S, Tohyama M. Roles of Bcl-2 and caspases in hypoxia-induced neuronal death: a possible neuroprotective mechanism of peptide growth factors. Mol Brain Res 1998; 58: 27-39.